Will Morton[email protected]Clinical NewsAmsterdam team evaluates Alzheimer's disease biomarkersA plasma tau biomarker and tau PET imaging performed equally well at identifying Alzheimer's disease pathology, yet tau PET appears superior for monitoring disease staging and clinical progression, according to Dutch investigators.October 20, 2022Molecular ImagingPET/CT scans predict low thyroid function in radiotherapy patientsEarly post-treatment PET/CT scans in patients undergoing radiotherapy for head and neck cancer may predict whether they later develop hypothyroidism, according to a study published on 10 October in Cancer Imaging.October 13, 2022Clinical NewsPET/CT radiomics model detects primary prostate cancerA PET/CT radiomics model based on imaging with a gallium-68 (Ga-68) PSMA-11 radiotracer could help clinicians diagnose primary prostate cancer, according to a study by Chinese researchers published September 30 in EJNMMI Research.October 11, 2022Molecular ImagingSPECT tracer shows promise in diagnosis of prostate cancerMore metastatic bone tumors can be diagnosed in patients with prostate cancer using SPECT/CT with an experimental radiotracer compared with conventional methods, a new global study has found.October 4, 2022Clinical NewsGlobal radiation issues generate discussion in ViennaImproving radiation medicine capabilities in poorer countries is essential to bridge the substantial worldwide differences in cancer care, delegates agreed at this week's International Atomic Energy Agency's 2022 Scientific Forum in Vienna.September 29, 2022Clinical NewsFrench team seeks to drive down FDG dose in PET/MRIResearchers from Sorbonne University in Paris are convinced that radiation doses in PET/MRI exams can be reduced significantly without compromising image quality in patients with neurological disorders.September 18, 2022Molecular ImagingHow widespread is fraud in nuclear medicine research?Leading Dutch researchers claim that fraud may be a problem in nuclear medicine journals, based on the results of their global survey. Their findings were published on 8 September in the Journal of Nuclear Medicine.September 12, 2022Clinical NewsCIRSE promotes highlights at 2022 annual meetingThe European Society of Cardiovascular and Interventional Radiology (CIRSE) will host its 38th annual meeting on 10-14 September in Barcelona, Spain. We look at what's going to be hot at this important congress.September 8, 2022Industry NewsHalf of global cancer deaths are due to risk factorsAlmost half of global cancer deaths are due to risk factors, with smoking, alcohol use, and high body mass index as the greatest contributors, according to research published on 18 August in the Lancet.September 7, 2022Molecular ImagingDanish team underlines value of PET tracer for neuroendocrine tumorsA new gallium-68 PET radiotracer appears to be effective for predicting higher risk of disease progression and mortality in patients with neuroendocrine tumors, according to a study from the University of Copenhagen.August 28, 2022Previous PagePage 11 of 20Next PageTop StoriesOrganized Radiology IssuesBeyond treatment: Europe's new focus on cancer prevention and screeningEurope’s cancer debate is shifting toward reducing risk, finding disease sooner and preventing some cancers from developing at all.CTneuroRAD’s next generation: “The future is already in the room”MRIESHNR President Robinson on science and connection at ASHNR 2026Womens ImagingAt EUSOBI, X-rays reveal art’s hidden storiesMRICardiac MRI-derived metrics predict adverse cardiac disease outcomes
